Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares have crashed 20% as of 12:00 PM ET on Thursday after delivering one of ...
Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma ...
“It’s very exciting,” a melanoma expert said of the experimental cancer vaccine announced by pharmaceutical companies Moderna ...
Moderna Inc. MRNA stock is trading lower after it rallied around 170% on Wednesday on upbeat data from individualized cancer ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced ...
Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so ...
Merck (MRK) stock slips as RBC Capital Markets cuts on valuation while Morgan Stanley upgrades on trial data for Moderna ...
Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...
Everyday Health on MSN
Personalized Cancer Vaccines Just Got One Step Closer to Reality
Adults at high risk of melanoma recurrence and spread were able to stay cancer-free with personalized vaccines made with mRNA ...
The 135-year-old drugmaker, founded in 1891 and now based in Rahway, New Jersey, announced a milestone that oncologists have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results